$EVEX
Eve Holding, Inc. Stock $evex

$evex Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000155485523000544 Filed on August 08, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$5.035M	$6.633M	$6.475M
YoY Change	-26.45%	2.43%	1407.78%
% of Gross Profit
Research & Development	$28.64M	$21.82M	$9.836M
YoY Change	100.31%	121.86%	407.31%
% of Gross Profit
Depreciation & Amortization	$40.00K	$81.08K	$0.00
YoY Change			-100.0%
% of Gross Profit
Operating Expenses	$33.68M	$28.45M	$16.31M
YoY Change	59.27%	74.45%	588.73%
Operating Profit	-$33.68M	-$28.45M	-$16.35M
YoY Change	-12.68%	74.05%	590.3%
Interest Expense	$1.950M	-$2.653M	$4.710M
YoY Change	-15.72%	-156.32%	529.51%
% of Operating Profit
Other Income/Expense, Net	$1.616M	$148.0K	-$13.77K
YoY Change	201.18%	-1174.8%
Pretax Income	-$30.11M	-$31.11M	-$11.65M
YoY Change	-16.94%	166.97%	382.56%
Income Tax	$1.098M	$303.0K	$129.7K
% Of Pretax Income
Net Earnings	-$31.21M	-$31.41M	-$11.78M
YoY Change	-15.06%	166.6%	387.93%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.11	-$0.11	-$0.43
Diluted Earnings Per Share	-$0.11	-$0.11	-$47.32K
COMMON SHARES
Basic Shares Outstanding	269.2M shares	269.1M shares	249.0M shares
Diluted Shares Outstanding	275.9M shares	275.6M shares	249.0M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$174.5M	$184.4M	$330.8M
YoY Change	-29.72%	-44.26%	24688.57%
Cash & Equivalents	$10.10M	$33.59M	$176.3M
Short-Term Investments	$164.4M	$150.8M	$154.5M
Other Short-Term Assets	$1.586M	$1.462M	$166.1K
YoY Change	-46.67%	780.24%	-23.82%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$259.6M	$270.8M	$331.2M
YoY Change	-22.08%	-18.24%	21234.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$477.9K	$513.8K
YoY Change	14.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$976.5K
YoY Change
Total Long-Term Assets	$1.989M	$1.064M	$0.00
YoY Change	375.05%		-100.0%
TOTAL ASSETS
Total Short-Term Assets	$259.6M	$270.8M	$331.2M
Total Long-Term Assets	$1.989M	$1.064M	$0.00
Total Assets	$261.6M	$271.9M	$331.2M
YoY Change	-21.58%	-17.92%	40.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.832M	$2.351M	$889.6K
YoY Change	-38.16%	164.23%
Accrued Expenses	$9.800M	$2.304M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$46.16M	$38.59M	$19.88M
YoY Change	64.75%	94.12%	666.9%
LONG-TERM LIABILITIES
Long-Term Debt	$11.32M	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.000M	$1.531M	$542.8K
YoY Change	138.42%	181.96%	-98.55%
Total Long-Term Liabilities	$13.35M	$1.531M	$542.8K
YoY Change	1491.17%	181.96%	-98.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$46.16M	$38.59M	$19.88M
Total Long-Term Liabilities	$13.35M	$1.531M	$542.8K
Total Liabilities	$59.51M	$40.12M	$20.42M
YoY Change	106.22%	96.46%	-48.86%
SHAREHOLDERS EQUITY
Retained Earnings	-$305.4M	-$274.2M	-$9.776M
YoY Change	55.06%	2704.61%
Common Stock	$507.4M	$505.9M	$320.6M
YoY Change	1.16%	57.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$202.0M	$231.7M	$310.8M
YoY Change
Total Liabilities & Shareholders Equity	$261.6M	$271.9M	$331.2M
YoY Change	-21.58%	-17.92%	40.24%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$31.21M	-$31.41M	-$11.78M
YoY Change	-15.06%	166.6%	387.93%
Depreciation, Depletion And Amortization	$40.00K	$81.08K	$0.00
YoY Change			-100.0%
Cash From Operating Activities	-$22.40M	-$27.71M	-$12.58M
YoY Change	32.1%	120.24%	7347.85%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$121.7K
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$12.00M	$49.50M	-$154.0M
YoY Change	-87.5%	-132.14%	6595.65%
Cash From Investing Activities	-$12.00M	$49.38M	-$154.0M
YoY Change	-87.55%	-132.06%	6595.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	11.00M	-287.2K	329.0M
YoY Change	-26.67%	-100.09%	14203.21%
NET CHANGE
Cash From Operating Activities	-22.40M	-27.71M	-12.58M
Cash From Investing Activities	-12.00M	49.38M	-154.0M
Cash From Financing Activities	11.00M	-287.2K	329.0M
Net Change In Cash	-23.40M	21.38M	162.4M
YoY Change	-76.21%	-86.84%	-96217.6%
FREE CASH FLOW
Cash From Operating Activities	-$22.40M	-$27.71M	-$12.58M
Capital Expenditures	$0.00	$121.7K
Free Cash Flow	-$22.40M	-$27.83M
YoY Change	35.45%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-31410026	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	58759	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Central Index Key EntityCentralIndexKey	0001823652
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	number
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	number
CY2023Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39704
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2549808
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1400 General Aviation Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	Melbourne
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32935
	dei	City Area Code CityAreaCode	(321)
	dei	Local Phone Number LocalPhoneNumber	751-5050
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	269163921	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33591771	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	49146063	usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	150782326	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	178781549	usd
CY2023Q2	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	313762	usd
CY2022Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	203712	usd
CY2023Q2	evex	Loans Receivable Related Parties Current LoansReceivableRelatedPartiesCurrent	84641828	usd
CY2022Q4	evex	Loans Receivable Related Parties Current LoansReceivableRelatedPartiesCurrent	82650375	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1461953	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1425507	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	270791640	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	312207206	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	513833	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	451586	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	550129	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	216636	usd
CY2023Q2	us-gaap	Assets Assets	271855602	usd
CY2022Q4	us-gaap	Assets Assets	312875428	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2097097	usd
CY2023Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	17733475	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	12625243	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	12541425	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3562500	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5961337	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6648171	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	38586777	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	24933011	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1530522	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1020074	usd
CY2023Q2	us-gaap	Liabilities Liabilities	40117299	usd
CY2022Q4	us-gaap	Liabilities Liabilities	25953085	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	269164	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	269094	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	505659469	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	503661571	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-274190330	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-217008322	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	231738303	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	286922343	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	271855602	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	312875428	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21821255	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10417278	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	43349593	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19531965	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6633106	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15728933	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12787425	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17046966	usd
CY2023Q2	evex	Expense Related To Issuance Of New Warrants ExpenseRelatedToIssuanceOfNewWarrants	0	usd
CY2022Q2	evex	Expense Related To Issuance Of New Warrants ExpenseRelatedToIssuanceOfNewWarrants	87352000	usd
	evex	Expense Related To Issuance Of New Warrants ExpenseRelatedToIssuanceOfNewWarrants	0	usd
	evex	Expense Related To Issuance Of New Warrants ExpenseRelatedToIssuanceOfNewWarrants	87352000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-28454361	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-113498211	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-56137018	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-123930931	usd
CY2023Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-6784425	usd
CY2022Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	5842500	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-8978925	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	5842500	usd
CY2023Q2	us-gaap	Investment Income Net InvestmentIncomeNet	2982448	usd
CY2022Q2	us-gaap	Investment Income Net InvestmentIncomeNet	824567	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	6236848	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	887948	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1149332	usd
CY2022Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-260713	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2173822	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	98618	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-31107006	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-107091857	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-56705273	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-117101865	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	303020	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	129708	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	476735	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	129708	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-31410026	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-107221565	usd
	us-gaap	Net Income Loss NetIncomeLoss	-57182008	usd
	us-gaap	Net Income Loss NetIncomeLoss	-117231573	usd
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.5
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.5
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	275632354	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	275632354	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	248989790	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	275563187	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	275563187	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	234574977	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	234574977	shares
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-31410026	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-107221565	usd
	us-gaap	Net Income Loss NetIncomeLoss	-57182008	usd
	us-gaap	Net Income Loss NetIncomeLoss	-117231573	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-31410026	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-107221565	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-57182008	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-117231573	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10699389	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-10010008	usd
CY2022Q1	evex	Increase Decrease Through Net Transfer From Parent Equity IncreaseDecreaseThroughNetTransferFromParentEquity	732776	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	746537	usd
CY2022Q2	evex	Increase Decrease Through Reclassification Of Public Warrants From Liability To Equity IncreaseDecreaseThroughReclassificationOfPublicWarrantsFromLiabilityToEquity	10580000	usd
CY2022Q2	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	87352000	usd
CY2022Q2	evex	Stock Issued During Period Value Reverse Recapitalization Net Of Fees StockIssuedDuringPeriodValueReverseRecapitalizationNetOfFees	315326717	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1935988	usd
CY2022Q2	evex	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	8000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	1028182	usd
CY2022Q2	evex	Increase Decrease Through Net Transfer From Parent Equity IncreaseDecreaseThroughNetTransferFromParentEquity	-2105409	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	307650450	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	286922343	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	867893	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	480000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	262498254	usd
CY2023Q2	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	69900	shares
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	650075	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	231738303	usd
	us-gaap	Net Income Loss NetIncomeLoss	-57182008	usd
	us-gaap	Net Income Loss NetIncomeLoss	-117231573	usd
	us-gaap	Depreciation Depreciation	103133	usd
	us-gaap	Depreciation Depreciation	0	usd
	evex	Noncash Lease Expenses Amortization And Interest NoncashLeaseExpensesAmortizationAndInterest	33710	usd
	evex	Noncash Lease Expenses Amortization And Interest NoncashLeaseExpensesAmortizationAndInterest	0	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	335838	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	136644	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1805122	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1935988	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	480000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	88380182	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-8978925	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	5842500	usd
	evex	Interest Income On Financial Investments InterestIncomeOnFinancialInvestments	4000777	usd
	evex	Interest Income On Financial Investments InterestIncomeOnFinancialInvestments	464652	usd
	evex	Interest Income On Related Party Loan Receivable InterestIncomeOnRelatedPartyLoanReceivable	1991453	usd
	evex	Interest Income On Related Party Loan Receivable InterestIncomeOnRelatedPartyLoanReceivable	0	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-20407	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-6098874	usd
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	109329	usd
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	36943	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	201622	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	2623858	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	5074539	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	1094121	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-681889	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1725014	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-47603836	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21854275	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	57500000	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	25500000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	154000000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	165380	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	31834620	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-154000000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	287154	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	0	usd
	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	354830252	usd
	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	0	usd
	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	15754066	usd
	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	0	usd
	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	1372633	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-287154	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	337703553	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	502078	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	90753	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-15554292	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	161940031	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49146063	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14376523	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33591771	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	176316554	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	387893	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	359516	usd
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	usd
	us-gaap	Stock Issued1 StockIssued1	954000	usd
	us-gaap	Stock Issued1 StockIssued1	1584800	usd
CY2022Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	0	usd
CY2023Q2	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	0	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14376523	usd
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	220000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	6274397	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	20870920	usd
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	699753	usd
CY2021Q4	us-gaap	Assets Assets	21570673	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	877641	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	8642340	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	32226	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	616156	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10168363	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	702921	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10871284	usd
CY2021Q4	evex	Net Parent Investment NetParentInvestment	10731615	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-32226	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10699389	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21570673	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="margin: 0px; line-height: 107%; font-size: 11pt; font-family: Calibri, sans-serif; text-indent: 0px;"><b><span style="font-size: 10.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Prior Period Reclassification</span></b></p> <p style="margin: 0pt; text-align: justify; line-height: 1.2;"><br/></p> <p style="margin: 0px; line-height: 107%; font-size: 11pt; font-family: Calibri, sans-serif; text-indent: 0px;"><span style="font-size: 10.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">We have reclassified certain prior period amounts to conform to the current period presentation. Exchange rate effects due to translation were reclassified from line items within “Changes in operating assets and liabilities” to “Unrealized gain on exchange rate translation” and “<span style="color: #000000;">Effect of exchange rate changes on cash and cash equivalents</span>” within the condensed consolidated statements of cash flows.</span></p> <p style="margin: 0pt; text-align: justify; line-height: 1.2;"><br/></p>
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 10pt; text-align: justify; text-indent: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt; font-weight: bold; line-height: inherit;">Use of Estimates </span></p> <p style="margin: 0px; text-align: justify; line-height: 1.2; font-size: 10pt; font-family: 'Times New Roman'; text-indent: 0px;"><span style="font-size: 10pt; font-family: 'Times New Roman', serif; line-height: inherit;"><span style="line-height: inherit;">The preparation of condensed consolidated financial statements in accordance with U.S. GAAP requires the Company’s management to make estimates and judgments that affected the reported amounts of assets and liabilities and allocations of expenses. These judgments were based on the historical experience, management’s evaluation of trends in the industry and other factors that were deemed relevant at that time. The estimates and assumptions were reviewed on a regular basis and the changes to accounting estimates were recognized in the period in which the estimates were revised. The Company’s management recognize that the actual results could be materially different from the estimates. </span><span style="line-height: inherit;"><span style="line-height: inherit;">Under the legal entity approach, the significant estimates include, </span></span><span style="line-height: inherit;">but are not limited to the measurement of warrants, fair value measurement and income taxes.</span></span></p>
CY2023Q2	us-gaap	Cash Cash	23392996	usd
CY2022Q4	us-gaap	Cash Cash	14446534	usd
CY2023Q2	evex	Private Securities At Carrying Value PrivateSecuritiesAtCarryingValue	5185486	usd
CY2022Q4	evex	Private Securities At Carrying Value PrivateSecuritiesAtCarryingValue	4483260	usd
CY2023Q2	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	5013289	usd
CY2022Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	30216269	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33591771	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	49146063	usd
	us-gaap	Maturity Of Time Deposits MaturityOfTimeDeposits	P90D
CY2023Q2	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	18245434	usd
CY2022Q2	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	15209119	usd
	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	33900956	usd
	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	23974247	usd
CY2023Q2	us-gaap	Prepaid Insurance PrepaidInsurance	1166293	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1292317	usd
CY2023Q2	evex	Advances To Employees AdvancesToEmployees	229200	usd
CY2022Q4	evex	Advances To Employees AdvancesToEmployees	74064	usd
CY2023Q2	us-gaap	Prepaid Taxes PrepaidTaxes	46603	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	34642	usd
CY2023Q2	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	19857	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	24484	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1461953	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1425507	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	597470	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	476465	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	83637	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	24879	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	513833	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	451586	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	36709	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
CY2023Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3478351	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	4075660	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2304112	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2491847	usd
CY2023Q2	evex	Advances From Customers Current AdvancesFromCustomersCurrent	1050000	usd
CY2022Q4	evex	Advances From Customers Current AdvancesFromCustomersCurrent	800000	usd
CY2023Q2	evex	Advanced Payments Related To Service Arrangements AdvancedPaymentsRelatedToServiceArrangements	546014	usd
CY2022Q4	evex	Advanced Payments Related To Service Arrangements AdvancedPaymentsRelatedToServiceArrangements	300738	usd
CY2023Q2	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	113382	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	0	usd
CY2023Q2	us-gaap	Other Liabilities OtherLiabilities	7491859	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	7668245	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5961337	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6648171	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1530522	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1020074	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	269163921	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	269163921	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	269094021	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	269094021	shares
	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one vote per share
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-31410026	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-107221565	usd
	us-gaap	Net Income Loss NetIncomeLoss	-117231573	usd
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	275632354	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	275632354	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	248989790	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	248989790	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	275563187	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	275563187	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	234574977	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	234574977	shares
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.5
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.5
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	57855631	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	54627235	shares
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.008	pure
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001	pure
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	476735	usd
CY2021Q3	us-gaap	Number Of Properties Subject To Ground Leases NumberOfPropertiesSubjectToGroundLeases	2	number
	us-gaap	Operating Lease Cost OperatingLeaseCost	0	usd
CY2023Q2	us-gaap	Number Of Properties Subject To Ground Leases NumberOfPropertiesSubjectToGroundLeases	2	number
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	338006	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	77531	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	260475	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21821255	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10417278	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	43349593	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19531965	usd

Files In Submission

Name	View Source	Status
0001554855-23-000544-index-headers.html	Edgar Link	pending
0001554855-23-000544-index.html	Edgar Link	pending
0001554855-23-000544.txt	Edgar Link	pending
0001554855-23-000544-xbrl.zip	Edgar Link	pending
evex-20230630.htm	Edgar Link	pending
evex-20230630.xsd	Edgar Link	pending
ex104_1.htm	Edgar Link	pending
ex311_2.htm	Edgar Link	pending
ex312_3.htm	Edgar Link	pending
ex313_4.htm	Edgar Link	pending
ex321_5.htm	Edgar Link	pending
ex322_6.htm	Edgar Link	pending
ex323_7.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
evex-20230630_def.xml	Edgar Link	unprocessable
evex-20230630_lab.xml	Edgar Link	unprocessable
evex-20230630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
evex-20230630_htm.xml	Edgar Link	completed
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
evex-20230630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EVEX
Eve Holding, Inc. Stock $evex

2023 Q3 Form 10-Q Financial Statement

#000155485523000544 Filed on August 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVEX Eve Holding, Inc. Stock $evex

2023 Q3 Form 10-Q Financial Statement

#000155485523000544 Filed on August 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVEX
Eve Holding, Inc. Stock $evex